ВМІСТ ЕНДОТЕЛІНУ-1 У КРОВІ ЯК МОЖЛИВИЙ БІОМАРКЕР ДІАБЕТИЧНОЇ РЕТИНОПАТІЇ
DOI:
https://doi.org/10.30890/2709-1783.2025-41-00-007Ключові слова:
type 2 diabetes, diabetic retinopathy, prognosis, modeling, endothelin-1, biomarkersАнотація
In a cohort of patients (136 people) with type 2 diabetes mellitus and diabetic retinopathy, an increase in the content of endothelin-1 in the blood serum was found, which allowed to determine its borderline levels at different stages of DR and predict itПосилання
Jenkins HN, Rivera-Gonzalez O, Gibert Y, Speed JS. Endothelin-1 in the pathophysiology of obesity and insulin resistance. Obes Rev. 2020 Dec;21(12):e13086. doi: 10.1111/obr.13086.
Ergul A. Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res. 2011 Jun;63(6):477-82. doi: 10.1016/j.phrs.2011.01.012.
Kostov K. The Causal Relationship between Endothelin-1 and Hypertension: Focusing on Endothelial Dysfunction, Arterial Stiffness, Vascular Remodeling, and Blood Pressure Regulation. Life (Basel). 2021 Sep 20;11(9):986. doi: 10.3390/life11090986.
Xu W, Wang HY, Zhao XH, Wang PJ. [Values of ocular hemodynamics and serum endothelin-1 in the early diagnosis of diabetic retinopathy]. Zhonghua Yi Xue Za Zhi. 2013 Jan 1;93(1):37-40. Chinese. PMID: 23578452.
Brownlee J. One-vs-Rest and One-vs-One for Multi-Class Classification [Internet]. Machine Learning Mastery; 2021 [cited 2025 May 28]. Available from: https://machinelearningmastery.com/one-vs-rest-and-one-vs-one-for-multi-class-classification.
Serdiuk AV, Mogilevskyy SYu, Zyablitzev SV, Denisiuk OYu. Effectiveness of treatment for different stages of diabetic retinopathy in type 2 diabetes. Mìžnarodnij endokrinologìčnij žurnal. 2024;7(20):491-498. [Ukrainian] https://doi.org/10.22141/2224-0721.20.7.2024.1447.
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2025 Автори
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
